340B Learning Collaborative
ACH’s 340B Learning Collaborative aims to conduct a deep exploration of the 340B Drug Pricing Program, which is crucial for federally qualified health centers (FQHCs), healthcare providers, patients, and policymakers alike, as it plays a significant role in improving access to affordable medications for underserved populations.
340B Learning Collaborative members, alongside experts in the field, will share the latest information on and best practices about 340B in order to better understand the intricacies of the program and effectively navigate its complexities. Through the LC, participants can gain a better grasp of 340B to help them identify opportunities for optimizing patient care, reducing health disparities, and ultimately enhancing the sustainability of healthcare systems.
Learn more